{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220225",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3/4",
          "submission_class_code_description": "Type 3 - New Dosage Form and Type 4 - New Combination",
          "application_docs": [
            {
              "id": "70321",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022388s000lbl.pdf",
              "date": "20220301",
              "type": "Label"
            },
            {
              "id": "70354",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022388Orig1s000ltr.pdf",
              "date": "20220302",
              "type": "Letter"
            },
            {
              "id": "72102",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/022388Orig1s000TOC.html",
              "date": "20220919",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220225",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "70303",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022388Orig1s000ltr.pdf",
              "date": "20220228",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA022388",
      "sponsor_name": "JOHNSON JOHNSON VISN",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ACUVUE THERAVISION WITH KETOTIFEN",
          "active_ingredients": [
            {
              "name": "KETOTIFEN FUMARATE",
              "strength": "EQ 19MCG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "DRUG-ELUTING CONTACT LENS",
          "route": "OPHTHALMIC",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}